Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Newmark Group
NMRK
$2.76B
| $5.39M | ﹤0.01% |
1,110,040
-210,272
| -16% | -$884K |
|
1602
Reynolds Consumer Products
REYN
$5.53B
| $5.38M | ﹤0.01% |
+155,000
| New | +$5.05M |
|
1603
Integer Holdings
ITGR
$4.26B
| $5.38M | ﹤0.01% |
73,700
+68,900
| +1,435% | +$5.01M |
|
|
ZVO
1604
DELISTED
Zovio Inc. Common Stock
ZVO
| $5.37M | ﹤0.01% |
1,755,306
-70,863
| -4% | -$161K |
|
1605
Crawford & Co Class A
CRD.A
$632M
| $5.37M | ﹤0.01% |
680,224
+9,800
| +1% | +$66.4K |
|
1606
Cactus
WHD
$5.88B
| $5.37M | ﹤0.01% |
260,100
-271,800
| -51% | -$4.71M |
|
1607
Home Bancorp
HBCP
$566M
| $5.36M | ﹤0.01% |
200,200
-15,200
| -7% | -$372K |
|
1608
iShares MSCI China ETF
MCHI
$6.16B
| $5.35M | ﹤0.01% |
+81,800
| New | +$5.02M |
|
1609
Manitowoc
MTW
$746M
| $5.33M | ﹤0.01% |
489,798
+296,600
| +154% | +$2.81M |
|
1610
ITT
ITT
$19.6B
| $5.32M | ﹤0.01% |
90,500
+45,066
| +99% | +$2.39M |
|
1611
Lantheus
LNTH
$6.59B
| $5.31M | ﹤0.01% |
371,611
-885,989
| -70% | -$11.7M |
|
1612
Aclaris Therapeutics
ACRS
$851M
| $5.31M | ﹤0.01% |
3,279,840
+104,204
| +3% | +$140K |
|
1613
Genie Energy
GNE
$383M
| $5.3M | ﹤0.01% |
720,397
+108,500
| +18% | +$850K |
|
1614
Western Alliance Bancorporation
WAL
$8.98B
| $5.3M | ﹤0.01% |
140,002
-139,802
| -50% | -$4.89M |
|
1615
AC Immune
ACIU
$253M
| $5.29M | ﹤0.01% |
786,011
+108,700
| +16% | +$790K |
|
1616
Purple Innovation
PRPL
$29.7M
| $5.29M | ﹤0.01% |
11,756
+7,260
| +161% | +$2.29M |
|
|
TEN
1617
Tsakos Energy Navigation Ltd
TEN
$1.25B
| $5.28M | ﹤0.01% |
525,361
-124,920
| -19% | -$1.72M |
|
1618
Mitek Systems
MITK
$877M
| $5.28M | ﹤0.01% |
549,081
+244,900
| +81% | +$2.21M |
|
1619
Rhythm Pharmaceuticals
RYTM
$7.95B
| $5.26M | ﹤0.01% |
235,900
+141,200
| +149% | +$2.75M |
|
|
DOO
1620
Bombardier Recreational Products
DOO
$4.73B
| $5.26M | ﹤0.01% |
123,500
-337,500
| -73% | -$10.1M |
|
|
COE
1621
51Talk Online Education Group
COE
$118M
| $5.25M | ﹤0.01% |
51,125
+25,625
| +100% | +$2.55M |
|
|
CLDR
1622
DELISTED
Cloudera, Inc.
CLDR
| $5.24M | ﹤0.01% |
411,852
-2,407,600
| -85% | -$23.1M |
|
1623
Huntington Ingalls Industries
HII
$12.9B
| $5.24M | ﹤0.01% |
30,000
+21,300
| +245% | +$3.96M |
|
1624
Yum China
YUMC
$16.3B
| $5.24M | ﹤0.01% |
108,900
-740,700
| -87% | -$34.9M |
|
|
GRP.U
1625
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $5.23M | ﹤0.01% |
101,300
+16,700
| +20% | +$782K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.